LGD-4033 (Ligandrol)

$39.99

In Stock
Category:

Summary

  • Massive Increase in Lean Muscle Mass
  • Increases Strength and Burns Fat
  • Muscles Look and Feel Full
  • Improves Recovery Time
  • PCT Required (Men Only)
  • Effective for both Male and Female Genders
  • Additional benefits: Gives a boost in energy, strength, speed, and endurance

Half-life of 24-36 hours

Description

LGD-4033 is often the most effective SARM for overall anabolism, muscle retention, and muscle growth. It is very potent, and reports of 10+ pounds of lean muscle gain are commonly reported from users. LGD-4033 is a selective androgen receptor modulator (SARM) developed to prevent muscle wasting, osteoporosis and a variety of other musculoskeletal degenerative diseases. It is non-steroidal, and is ingested orally. Comparing LGD-4033 to Ostarine head to head, LGD-4033 exhibits greater levels of anabolic activity at a lower dosage, but is far more suppressive than Ostarine. It is close to 12 times more powerful than Ostarine.

Benefits of Ligandrol

Research has found that Ligandrol aids in muscle building and increasing strength as well as endurance. Some of its known benefits according  to the tests done include:

  • Massive increase in lean muscle mass
  • Increases strength and burns fat
  • Muscles look and feel full
  • Improves recovery time
  • Boost energy, strength, speed, and endurance

Possible Side Effects

Ligandrol (LGD-4033) has not been found to be associated with any significant side effects so far but it does not mean that no side effects are to be expected at all. Studies performed has revealed that it can cause serious testosterone suppression while also bringing sex hormones to lower levels.

Recommended Dosing:

LGD-4033 (Ligadrol)
Goals Men Women Cycle Length PCT Selection (Men Only)
Building Muscle 10-25mg/day 10-15mg/day 8-10 weeks PCT Table (Heavy PCT)
Maintaining Muscle 5-10mg/day 5-10mg/day 6-12 weeks PCT Table (Normal PCT)
It is recommended to take 6-8 weeks off from SARMS upon completing a cycle

 References: